FDA Will Hold Public Workshop on Medical Device Cybersecurity

December 8, 2015

In collaboration with the National Health Information Sharing Analysis Center (NH-ISAC) and the Department of Health and Human Services, FDA is planning to hold a public workshop entitled “Moving Forward: Collaborative Approaches to Medical Device Cybersecurity.” This workshop will be held at FDA’s White Oak Campus in Silver Spring, Maryland, on January 20 – 21, 2016.

The purpose of the workshop is to “highlight past collaborative efforts; increase awareness of existing maturity models (i.e. frameworks leveraged for benchmarking an organization's processes) which are used to evaluate cybersecurity status, standards, and tools in development; and to engage the multi-stakeholder community in focused discussions on unresolved gaps and challenges that have hampered progress in advancing medical device cybersecurity.”

The workshop follows FDA publishing an alert regarding the cybersecurity of an approved medical device. The alert was published on July 31, 2015, and informed users of the Hospira Symbiq Infusion System (Version 3.13 and prior versions) of the device’s cybersecurity vulnerabilities. In the alert, FDA stated that the Agency strongly encourages “that health care facilities transition to alternative infusion systems, and discontinue use of these pumps.”

In addition, the Agency published a final guidance in October 2014 in which FDA recommended “that manufacturers consider cybersecurity risks as part of the design and development of a medical device, and submit documentation to the FDA about the risks identified and controls in place to mitigate those risks.”

As medical device cybersecurity continues to become a more imminent threat, it is comforting to see FDA taking a proactive approach.

Are you in the process of developing a medical device? Do you have a device that needs FDA approval? We can help. Using our proprietary approach, we can help get your product through FDA cheaper, better, and faster. To learn more about our services and how we can help you, please contact us.

Agency Alerts General Regulatory

October 1, 2015

Will FDA Change the Definition of “Intended Use”?

FDA released proposed regulation that would allow sponsors to determine if their product is a drug/device, or if it is not a drug/device. Last week, the Agency announced a proposed rule “to provide...

Read the Full Article
General Regulatory Regulatory Sciences

March 31, 2015

Drug Development Questions And The FDA - The End Of The Black Hole

Commonly during drug development, significant issues arise for which FDA input is desired but that do not merit a full face-to-face multidisciplinary milestone meeting. In many cases, sponsors are...

Read the Full Article
Agency Alerts

March 21, 2016

Direct-to-Consumer (DTC) Drug Advertisements, Part Three

FDA’s Proposed Study on Consumer Understanding of Quantitative Information in DTC Drug Ads In October 2015, the FDA announced plans to conduct a study which would determine how much quantitative...

Read the Full Article